Aspen Pharmacare Holdings Limited (JSE:APN)

Market Cap	58.34B -26.6%
Revenue (ttm)	42.59B +2.8%
Net Income	-2.00B
EPS	-4.50
Shares Out	444.02M
PE Ratio	n/a
Forward PE	12.79
Dividend	2.11 (1.65%)
Ex-Dividend Date	Oct 1, 2025

Volume	914,824
Average Volume	1,448,353
Open	12,718
Previous Close	12,800
Day's Range	12,718 - 13,140
52-Week Range	9,070 - 16,705
Beta	0.37
RSI	45.51
Earnings Date	Mar 3, 2026

About Aspen Pharmacare Holdings

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counte...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1850
• Employees: 9,557
• Stock Exchange: Johannesburg Stock Exchange
• Ticker Symbol: APN